Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies

Area of Science:

• Cardiology
• Rheumatology
• Systemic Autoimmune Diseases

Background:

• Primary heart involvement is common in systemic sclerosis (SSc), often presenting as sub-clinical cardiac abnormalities.
• These cardiac issues are typically a direct result of SSc, not other complications.
• Timely diagnosis is critical for effective SSc-related heart disease management and preventing life-threatening complications.

Purpose of the Study:

• To review current literature on the diagnosis and management of primary heart involvement in systemic sclerosis.
• To explore novel insights into the pathogenic mechanisms of SSc-related cardiac abnormalities.
• To identify potential therapeutic targets and novel treatment strategies for SSc-associated heart disease.

Main Methods:

• Comprehensive literature review of existing studies on systemic sclerosis and cardiac involvement.
• Analysis of current management strategies and therapeutic approaches.
• Exploration of recent findings on the pathogenesis of SSc-related heart disease.

Main Results:

• Systemic sclerosis frequently leads to cardiac abnormalities, often sub-clinical.
• Current evidence for managing SSc-primary heart involvement is limited, with a lack of specific treatment guidelines.
• Understanding pathogenic mechanisms is key to developing targeted therapies.

Conclusions:

• Primary cardiac involvement is a significant manifestation of systemic sclerosis requiring prompt diagnosis and management.
• There is an unmet need for evidence-based treatment recommendations and a unified approach to managing SSc-related heart disease.
• Further research into pathogenic mechanisms will guide the development of novel therapeutic strategies.